Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Morelli

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|May 18, 2018
Heart rate reduction with ivabradine in the early phase of atherosclerosis is protective in the endothelium of ApoE-deficient miceG Aquila, M B Morelli, F Vieceli Dalla Sega, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2011
ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cellsPeter Duewell, Ulrich Kisser, Klaus Heckelsmiller, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|May 18, 2018
Heart rate reduction with ivabradine in the early phase of atherosclerosis is protective in the endothelium of ApoE-deficient miceG Aquila, M B Morelli, F Vieceli Dalla Sega, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2011
ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cellsPeter Duewell, Ulrich Kisser, Klaus Heckelsmiller, et al.
Pageof 4